-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Moleculin Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q1 2025.
- Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $485K, a 1.62% decline year-over-year.
- Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $1.72M, a 13.1% decline year-over-year.
- Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.73M, a 13% decline from 2023.
- Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.98M, a 12.8% decline from 2022.
- Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.28M, a 4.13% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)